Clinical Trials Browser

Phase 1 × OTHER × Tablets × Clear all

NCT05330377 2023-04-25

GM-CLAG in Relapsed/Refractory FLT3-mutated AML

Phase 1 Withdrawn

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT01173913 2019-01-10

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir

Phase 1 Completed

Neoplasms

NCT00667485 2014-01-17

Rapamycin Plus Bevacizumab in Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis